Cancer News and Research

Latest Cancer News and Research

Researchers identify enzymes that are crucial for growth of cancers with genetic aberrations in p53

The most frequently mutated gene across all types of cancers is a gene called p53. Unfortunately it has been difficult to directly target this gene with drugs. Now a multi-institutional research team, led by Dr. Lewis Cantley and investigators at Weill Cornell Medical College, has identified a family of enzymes they say is crucial for the growth of cancers that have genetic aberrations in p53.

8 Nov 2013

Lactoferricin B25 derived from cow's milk shows promise for treatment of gastric cancer

New research from a team of researchers in Taiwan indicates that a peptide fragment derived from cow's milk, known as lactoferricin B25 (LFcinB25), exhibited potent anticancer capability against human stomach cancer cell cultures.

8 Nov 2013

New coverage gaps, cost issues spur health law worries

News outlets look at the nuts and bolts of the health law's implementation, including a worry that coverage gaps will persist for some vulnerable people, as well as how the government pays for insurance subsidies and why some premium costs increase under the health law.

8 Nov 2013

Consumption of tree nuts inversely associated with risk of pancreatic cancer in women

In a large prospective study published online in the British Journal of Cancer, researchers looked at the association between nut consumption and risk of pancreatic cancer among 75,680 women in the Nurses' Health Study, with no previous history of cancer.

8 Nov 2013

UC researchers receive FDA grant to study generic tacrolimus in high-risk transplant patients

Transplant researchers at the University of Cincinnati have received a grant from the U.S. Food and Drug Administration to study the safety and efficacy of a generic immunosuppressive drug in high-risk transplant patients.

7 Nov 2013

Mental health services, tobacco control programs must work together to encourage smoking cessation

Persons with mental illness account for more than one-third of adult smokers in the United States and despite a decline in tobacco use during the past five decades, there has been no change in the smoking rate for patients with poor mental health.

7 Nov 2013

Inhibition of heart protein reduces damage from heart attack, say researchers

The stop and start of blood flow to the heart during and after a heart attack causes severe damage to heart cells, reducing their capacity to function and potentially causing their death.

7 Nov 2013

ImmunGene secures $9 million in Series A financing from Ally Bridge Group

ImmunGene, Inc., a biotechnology company focused on developing antibody-cytokine fusion technology therapies to treat cancer, today announced it has secured $9 million in a milestone-based Series A financing from Ally Bridge Group. Previous investments in the Company were converted into Series A preferred stock. ImmunGene will use the capital to advance its early-stage development products to IND-enabling studies.

7 Nov 2013

HCSA Annual Conference sponsored by PENTAX Medical to focus on new health procurement strategy

PENTAX Medical is a key sponsor of this year’s Health Care Supply Association Annual Conference and Exhibition, which takes place in Manchester, 13-14 November. One of the keynote speakers – Peter Smith – will be presenting the PENTAX Medical sponsored talk entitled: “The new health procurement strategy – a commentator and supplier view”, which takes place on Thursday 14th November, at 9am.

From PENTAX Medical Company 7 Nov 2013

Patrys receives FDA Orphan Medicinal Product Designation for PAT-SM6

Patrys Limited, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal Product Designation for its lead anti-cancer product PAT-SM6, from the USA Food and Drugs Administration.

7 Nov 2013

UCLA launches first university-based military medicine center to care for wounded veterans

UCLA has launched the first university-based military medicine center on the West Coast, thanks to a generous donation from two sons in honor their father, the inventor, entrepreneur and philanthropist Ronald A. Katz.

7 Nov 2013

Investigators find potential new target for treatment of low-grade gliomas

Investigators at Johns Hopkins have found a known genetic pathway to be active in many difficult-to-treat pediatric brain tumors called low-grade gliomas, potentially offering a new target for the treatment of these cancers.

7 Nov 2013

Majerus to donate $2M for new Primary Children's and Families' Cancer Research Center at HCI

Today the Majerus Family Foundation (a foundation Rick Majerus, former University of Utah basketball coach from 1989-2004, established prior to his death in 2012) announced that it will make a gift in the amount of $2 million toward the construction of the new Primary Children's and Families' Cancer Research Center at Huntsman Cancer Institute.

7 Nov 2013

Researchers, clinicians discuss recent findings that could bring hope for people with HIV

Since the onset of the AIDS pandemic more than three decades ago, researchers from the lab and physicians in the clinic have been working toward one shared goal: an AIDS-free world. This week, a conference hosted by the journals Cell and The Lancet brought leading researchers and clinicians together to discuss recent findings that could bring hope to the estimated 35 million people world-wide who live with HIV.

7 Nov 2013

MGH researchers identify probable mechanism for pain-induced cognitive impairment

The pain caused by a surgical incision may contribute to the risk of postoperative cognitive dysfunction, a sometimes transient impairment in learning and memory that affects a small but significant number of patients in the days following a surgical procedure.

7 Nov 2013

New study uses genomic sequencing to develop treatments for castration-resistant prostate cancer

A new study at Mayo Clinic is using genomic sequencing to develop customized treatments for men with castration-resistant prostate cancer, a progressive and incurable stage of prostate cancer, which no longer responds to hormone therapies that stop or slow testosterone production.

7 Nov 2013

Tea helps promote weight loss and improve bone health

Decades worth of research shows that tea-the second most consumed beverage in the world-may help prevent chronic illnesses, including heart disease, certain types of cancer and type 2 diabetes. New research shows tea has been found to help promote weight loss and maintain a healthy weight, improve bone health and activate areas of the brain that bolster attention, problem solving and mood.

7 Nov 2013

Parent's use of digital photography shown as effective tool in diagnosis of retinoblastoma

Can parents use digital cameras and smart phones to potentially screen their children for the most common form of pediatric eye cancer? Baylor University and Harvard Medical School researchers believe so.

7 Nov 2013

MU researchers find more accurate laboratory method for diagnosing pancreatic cancer

Researchers from the University of Missouri have found a more accurate laboratory method for diagnosing pancreatic cancer, the fourth leading cause of cancer death in the United States. The disease causes more than 38,000 deaths each year in the United States, and kills 94 percent of people with the illness within five years, according to the National Cancer Institute.

7 Nov 2013

UnitedHealthcare CEO: Medicare advantage benefit cuts are 'the new frontier'

AARP Medicare plans, administered by insurance giant UnitedHealthCare, have been under scrutiny lately for belt tightening, ranging from dropping Silver Sneakers to dropping thousands of physicians from their networks.

7 Nov 2013

Cancer News and Research

Latest Cancer News and Research

Researchers identify enzymes that are crucial for growth of cancers with genetic aberrations in p53

Lactoferricin B25 derived from cow's milk shows promise for treatment of gastric cancer

New coverage gaps, cost issues spur health law worries

Consumption of tree nuts inversely associated with risk of pancreatic cancer in women

UC researchers receive FDA grant to study generic tacrolimus in high-risk transplant patients

Mental health services, tobacco control programs must work together to encourage smoking cessation

Inhibition of heart protein reduces damage from heart attack, say researchers

ImmunGene secures $9 million in Series A financing from Ally Bridge Group

HCSA Annual Conference sponsored by PENTAX Medical to focus on new health procurement strategy

Patrys receives FDA Orphan Medicinal Product Designation for PAT-SM6

UCLA launches first university-based military medicine center to care for wounded veterans

Investigators find potential new target for treatment of low-grade gliomas

Majerus to donate $2M for new Primary Children's and Families' Cancer Research Center at HCI

Researchers, clinicians discuss recent findings that could bring hope for people with HIV

MGH researchers identify probable mechanism for pain-induced cognitive impairment

New study uses genomic sequencing to develop treatments for castration-resistant prostate cancer

Tea helps promote weight loss and improve bone health

Parent's use of digital photography shown as effective tool in diagnosis of retinoblastoma

MU researchers find more accurate laboratory method for diagnosing pancreatic cancer

UnitedHealthcare CEO: Medicare advantage benefit cuts are 'the new frontier'

Understanding the DNA Damage Response in Innate Immunity eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Newsletters you may be interested in